ID   KBH5.0
AC   CVCL_D644
DR   BTO; BTO_0005296
DR   Wikidata; Q54899581
RX   PubMed=14679002;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_51232; 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole (Hoechst 33342; Hoe 33342).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
RX   PubMed=14679002;
RA   Li, Tsai-Kun
RA   Houghton, Peter J.
RA   Desai, Shyamal D.
RA   Daroui, Parima
RA   Liu, Angela A.
RA   Hars, Eszter S.
RA   Ruchelman, Alexander L.
RA   LaVoie, Edmond J.
RA   Liu, Leroy Fong
RT   "Characterization of ARC-111 as a novel topoisomerase I-targeting
RT   anticancer drug.";
RL   Cancer Res. 63:8400-8407(2003).
//